These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8081074)
1. The 5-lipoxygenase inhibitory activity of zileuton in in vitro and in vivo models of antigen-induced airway anaphylaxis. Malo PE; Bell RL; Shaughnessy TK; Summers JB; Brooks DW; Carter GW Pulm Pharmacol; 1994 Apr; 7(2):73-9. PubMed ID: 8081074 [TBL] [Abstract][Full Text] [Related]
4. Dose-dependent mediation of leukotriene D4-induced airway microvascular leakage and bronchoconstriction in the guinea pig. Bochnowicz S; Underwood DC Prostaglandins Leukot Essent Fatty Acids; 1995 Jun; 52(6):403-11. PubMed ID: 7644563 [TBL] [Abstract][Full Text] [Related]
5. Effect of BI-L-239, A-64077 and MK-886 on leukotriene B4 synthesis by chopped guinea pig lung and on antigen-induced tracheal contraction in vitro. Noonan TC; Jamieson-Leclercq T; Desai SN Prostaglandins; 1992 Dec; 44(6):543-54. PubMed ID: 1335586 [TBL] [Abstract][Full Text] [Related]
6. Effect of BW B70C, a novel inhibitor of arachidonic acid 5-lipoxygenase, on allergen-induced bronchoconstriction and late-phase lung eosinophil accumulation in sensitised guinea-pigs. Yeadon M; Dougan FL; Petrovic A; Beesley JE; Payne AN Agents Actions; 1993 Jan; 38(1-2):8-18. PubMed ID: 8480540 [TBL] [Abstract][Full Text] [Related]
7. The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheep. Abraham WM; Ahmed A; Cortes A; Sielczak MW; Hinz W; Bouska J; Lanni C; Bell RL Eur J Pharmacol; 1992 Jul; 217(2-3):119-26. PubMed ID: 1330588 [TBL] [Abstract][Full Text] [Related]
8. WY-50, 295 tromethamine: an orally active 5-lipoxygenase inhibitor with anti-allergic activity. Weichman BM; Berkenkopf JW; Chang JY; Heaslip RJ; Kreft AF; Lewis AJ; Musser JH; Grimes D Agents Actions Suppl; 1991; 34():201-9. PubMed ID: 1793064 [TBL] [Abstract][Full Text] [Related]
9. Effect of 5-lipoxygenase inhibitors on the anti-IgE-induced contraction of passively sensitized human bronchus in vitro. Poaty V; Riquet M; LeGall G; Frossard N J Lipid Mediat; 1993 Oct; 8(2):105-10. PubMed ID: 8268454 [TBL] [Abstract][Full Text] [Related]
10. The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor. Bell RL; Young PR; Albert D; Lanni C; Summers JB; Brooks DW; Rubin P; Carter GW Int J Immunopharmacol; 1992 Apr; 14(3):505-10. PubMed ID: 1618602 [TBL] [Abstract][Full Text] [Related]
11. Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenase. Malamas MS; Carlson RP; Grimes D; Howell R; Glaser K; Gunawan I; Nelson JA; Kanzelberger M; Shah U; Hartman DA J Med Chem; 1996 Jan; 39(1):237-45. PubMed ID: 8568813 [TBL] [Abstract][Full Text] [Related]
12. Failure of a combined anti-histamine and anti-leukotriene treatment to suppress passive anaphylaxis in the guinea-pig. Garcez Do Carmo L; Cordeiro R; Lagente V; Lefort J; Randon J; Vargaftig BB Int J Immunopharmacol; 1986; 8(8):985-95. PubMed ID: 2879805 [TBL] [Abstract][Full Text] [Related]
13. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Jones TR; Zamboni R; Belley M; Champion E; Charette L; Ford-Hutchinson AW; Frenette R; Gauthier JY; Leger S; Masson P Can J Physiol Pharmacol; 1989 Jan; 67(1):17-28. PubMed ID: 2540892 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of antigen-induced contraction of guinea-pig airways by a leukotriene synthesis inhibitor, BAY x1005. Gardiner PJ; Cuthbert NJ; Francis HP; Fitzgerald MF; Thompson AM; Carpenter TG; Patel UP; Newton BB; Mohrs K; Müller-Peddinghaus R Eur J Pharmacol; 1994 Jun; 258(1-2):95-102. PubMed ID: 7925604 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of antigen-induced contraction of guinea pig trachea by ICI 198,615. Redkar-Brown DG; Aharony D Eur J Pharmacol; 1989 Jun; 165(1):113-21. PubMed ID: 2767127 [TBL] [Abstract][Full Text] [Related]
16. Insights into IgE-mediated lung inflammation derived from a study employing a 5-lipoxygenase inhibitor. Kane GC; Tollino M; Pollice M; Kim CJ; Cohn J; Murray JJ; Dworski R; Sheller J; Fish JE; Peters SP Prostaglandins; 1995 Jul; 50(1):1-18. PubMed ID: 8588068 [TBL] [Abstract][Full Text] [Related]
17. Preclinical and clinical activity of zileuton and A-78773. Bell RL; Lanni C; Malo PE; Brooks DW; Stewart AO; Hansen R; Rubin P; Carter GW Ann N Y Acad Sci; 1993 Nov; 696():205-15. PubMed ID: 8109828 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of 5-lipoxygenase inhibitors, zileuton, A-78773 and ICI-D-2138 in an ionophore (A-23187)-induced pleural inflammation model in the rat. Rao TS; Currie JL; Shaffer AF; Isakson PC Life Sci; 1993; 53(9):PL147-52. PubMed ID: 8394967 [TBL] [Abstract][Full Text] [Related]
20. 5-lipoxygenase inhibitory activity of zileuton. Carter GW; Young PR; Albert DH; Bouska J; Dyer R; Bell RL; Summers JB; Brooks DW J Pharmacol Exp Ther; 1991 Mar; 256(3):929-37. PubMed ID: 1848634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]